The first member of this group, ABCC1 (also called MRP-1), has garnered a high degree of interest due to its dysregulation in many forms of cancer including glioma, non-small cell lung cancer (NSCLC), acute myeloid leukemia (AML), and acute lymphocytic leukemia (ALL). This evidence concerns the gene ABCC1 and acute lymphoblastic leukemia.